<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Nanomedicine &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/nanomedicine/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 14:25:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Nanomedicine &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Nanosystem Targets TIMP-1 for Continuous Lung Fibrosis Therapy</title>
		<link>https://bioengineer.org/nanosystem-targets-timp-1-for-continuous-lung-fibrosis-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 14:24:54 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Based on the content and focus of the article]]></category>
		<category><![CDATA[Based on the content focusing on a novel nanosystem targeting TIMP-1 for continuous]]></category>
		<category><![CDATA[Continuous Drug Delivery]]></category>
		<category><![CDATA[here are 5 appropriate tags: **Lung Fibrosis Therapy]]></category>
		<category><![CDATA[here are 5 appropriate tags: **TIMP-1 targeted therapy]]></category>
		<category><![CDATA[idiopathic pulmonary fibrosis]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Nanosystem drug delivery]]></category>
		<category><![CDATA[Spatiotemporal drug release]]></category>
		<category><![CDATA[spatiotemporally controlled therapy of idiopathic pulmonary fibrosis (IPF)]]></category>
		<category><![CDATA[Targeted Drug Delivery** **Explanation:** 1. **Lung Fibrosis Therapy:** Directly addresses the disease being treated (idiopathic pulmonary fibrosis/IPF). 2. **T]]></category>
		<category><![CDATA[TIMP-1 Targeting]]></category>
		<guid isPermaLink="false">https://bioengineer.org/nanosystem-targets-timp-1-for-continuous-lung-fibrosis-therapy/</guid>

					<description><![CDATA[In a groundbreaking leap forward for pulmonary medicine, a team of researchers led by Li, C., Lu, G., Chen, H., and colleagues has developed an innovative nanosystem designed to tackle idiopathic pulmonary fibrosis (IPF) through continuous spatiotemporal therapy. Published in Nature Communications in 2026, this pioneering study introduces a novel approach to delivering targeted treatment [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318368</post-id>	</item>
		<item>
		<title>Nanomedicine: Promoting Equity in Head and Neck Cancer Care</title>
		<link>https://bioengineer.org/nanomedicine-promoting-equity-in-head-and-neck-cancer-care/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jan 2026 09:13:23 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Brazil` **Bu etiketlerin seçilme nedenleri:** 1. **Nanomedicine:** Makalenin temel teknolojik odağı ve ana araştırma konusu. 2. **Head and Neck Cancer:** Makalenin spes]]></category>
		<category><![CDATA[Cost Reduction]]></category>
		<category><![CDATA[Head and neck cancer]]></category>
		<category><![CDATA[health equity]]></category>
		<category><![CDATA[healthcare equity]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket (virgülle ayrılmış): `Nanomedicine]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/nanomedicine-promoting-equity-in-head-and-neck-cancer-care/</guid>

					<description><![CDATA[In a groundbreaking study that explores the intersection of nanomedicine and public health, researchers L.M. de Andrade and L.O. Ladeira present a compelling case for the integration of advanced technologies in the treatment of head and neck cancers in Brazil. As the nation grapples with significant healthcare disparities, this research sheds light on how innovative [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317434</post-id>	</item>
		<item>
		<title>Thymol-Chitosan Nanoparticles Combat Toxocara Larvae In Vitro</title>
		<link>https://bioengineer.org/thymol-chitosan-nanoparticles-combat-toxocara-larvae-in-vitro/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jan 2026 13:47:30 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[antiparasitic nanoparticles** **Açıklama:** 1. **Thymol-chitosan nanoparticles:** Çalışmanın temel konusu ve geliştirilen yenilikçi formülasyon. 2. **Toxocara vit]]></category>
		<category><![CDATA[İşte 5 uygun etiket (virgülle ayrılmış): **Thymol-chitosan nanoparticles]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Toxocara vitulorum]]></category>
		<category><![CDATA[veterinary parasitology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/thymol-chitosan-nanoparticles-combat-toxocara-larvae-in-vitro/</guid>

					<description><![CDATA[In a groundbreaking advancement in parasitology and nanotechnology, researchers have unveiled a promising new approach for combating Toxocara vitulorum infective larvae using thymol-loaded chitosan nanoparticles. This innovative method not only epitomizes the power of nanomedicine in addressing parasitic infections but also underscores the potential of natural compounds in enhancing therapeutic efficacy. Toxocara vitulorum, a notorious [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316494</post-id>	</item>
		<item>
		<title>Chlorella Nanogels Suppress Lung Injury Inflammation</title>
		<link>https://bioengineer.org/chlorella-nanogels-suppress-lung-injury-inflammation/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 03:22:35 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cGAS-STING pathway]]></category>
		<category><![CDATA[Chlorella nanogels]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Radiation-induced lung injury]]></category>
		<guid isPermaLink="false">https://bioengineer.org/chlorella-nanogels-suppress-lung-injury-inflammation/</guid>

					<description><![CDATA[In a groundbreaking advancement at the intersection of biotechnology and radiation medicine, researchers have identified a novel nanogel derived from Chlorella extracellular vesicles that demonstrates remarkable therapeutic potential against radiation-induced lung injury (RILI). Published in Nature Communications in 2026, this study by Hu, Lu, Zhang, and colleagues unveils an innovative approach targeting the cGAS-STING signaling [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315134</post-id>	</item>
		<item>
		<title>Revolutionizing Breast Cancer Detection with DNA Nanostructures</title>
		<link>https://bioengineer.org/revolutionizing-breast-cancer-detection-with-dna-nanostructures/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 24 Dec 2025 08:26:37 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[breast cancer detection]]></category>
		<category><![CDATA[DNA nanostructures]]></category>
		<category><![CDATA[Molecular diagnostics]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[precision oncology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/revolutionizing-breast-cancer-detection-with-dna-nanostructures/</guid>

					<description><![CDATA[In a groundbreaking leap at the nexus of nanotechnology and oncology, recent advancements in DNA nanostructure research are charting an unprecedented path toward the early detection of breast cancer, potentially revolutionizing diagnostic methodologies. As breast cancer remains one of the most pervasive malignancies globally, the urgency to refine detection tools has never been greater. Scientists [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">310850</post-id>	</item>
		<item>
		<title>Metallic Nanoparticles Combat Staphylococcus Infections: Review Insights</title>
		<link>https://bioengineer.org/metallic-nanoparticles-combat-staphylococcus-infections-review-insights/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 12 Dec 2025 18:07:26 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antibacterial mechanisms]]></category>
		<category><![CDATA[antibiotic resistance]]></category>
		<category><![CDATA[Metallic nanoparticles]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Staphylococcus aureus]]></category>
		<guid isPermaLink="false">https://bioengineer.org/metallic-nanoparticles-combat-staphylococcus-infections-review-insights/</guid>

					<description><![CDATA[In recent years, the utilization of metallic nanoparticles in combating bacterial infections has gained significant attention within the scientific community. One of the most formidable pathogens, Staphylococcus aureus, poses a substantial threat to human health due to its ability to develop resistance against conventional antibiotics. In light of this challenge, a new study has emerged, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">306868</post-id>	</item>
		<item>
		<title>Trimetallic and Bimetallic Nanofluids: Antimalarial Breakthroughs</title>
		<link>https://bioengineer.org/trimetallic-and-bimetallic-nanofluids-antimalarial-breakthroughs/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 11 Dec 2025 10:42:40 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antimalarial activity]]></category>
		<category><![CDATA[Bimetallic nanofluids]]></category>
		<category><![CDATA[Malaria treatment]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Trimetallic nanofluids]]></category>
		<guid isPermaLink="false">https://bioengineer.org/trimetallic-and-bimetallic-nanofluids-antimalarial-breakthroughs/</guid>

					<description><![CDATA[Recent developments in nanomaterials have paved the way for breakthroughs in various fields, particularly in biomedical sciences. The latest research by Dubey et al. embodies this progress, focusing on the synergistic effects of trimetallic and bimetallic nanofluids on combating malaria, demonstrating notable cytotoxic and antioxidant activities. This study, published in BMC Pharmacology and Toxicology in [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">305795</post-id>	</item>
		<item>
		<title>ERC Synergy Grant Enhances Insights into the Blood-Nerve Interface to Revolutionize Pain Management</title>
		<link>https://bioengineer.org/erc-synergy-grant-enhances-insights-into-the-blood-nerve-interface-to-revolutionize-pain-management/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 06 Nov 2025 16:48:01 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[blood-nerve barrier]]></category>
		<category><![CDATA[drug delivery systems]]></category>
		<category><![CDATA[ERC Synergy Grant]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Pain Management]]></category>
		<guid isPermaLink="false">https://bioengineer.org/erc-synergy-grant-enhances-insights-into-the-blood-nerve-interface-to-revolutionize-pain-management/</guid>

					<description><![CDATA[Unlocking the Secrets of the Blood-Nerve Barrier: A Revolutionary Approach to Pain Management In a groundbreaking initiative, Professor Tambet Teesalu of the University of Tartu has received an ERC Synergy Grant to delve into the complexities of the blood-nerve barrier. This critical interface between blood vessels and nerve cells plays a significant role in our [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">292721</post-id>	</item>
		<item>
		<title>Breakthrough in Cancer Treatment: Development of Versatile Liquid Metal Nanocomposites for Enhanced Photoimmunotherapy</title>
		<link>https://bioengineer.org/breakthrough-in-cancer-treatment-development-of-versatile-liquid-metal-nanocomposites-for-enhanced-photoimmunotherapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 25 Sep 2025 13:57:28 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[Enhanced Permeability and Retention Effect]]></category>
		<category><![CDATA[Liquid Metal Nanocomposites]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[Photothermal Therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/breakthrough-in-cancer-treatment-development-of-versatile-liquid-metal-nanocomposites-for-enhanced-photoimmunotherapy/</guid>

					<description><![CDATA[A groundbreaking study led by Professor Eijiro Miyako and his research team at the Japan Advanced Institute of Science and Technology (JAIST) has introduced an innovative class of nanocomposites that could revolutionize cancer treatment. These multifunctional nanoparticles combine the biocompatibility of current liquid metals with components derived from lactic acid bacteria, all while incorporating the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">272200</post-id>	</item>
	</channel>
</rss>
